Kairos Pharma replaces auditor Marcum with Weinberg; 2023 report had going concern

Kairos Pharma, LTD.

Audit committee dismissed Marcum LLP and appointed Weinberg & Company effective April 23, 2025.
Marcum's 2023 audit report included a going concern uncertainty; 2024 report had no such modification.
No disagreements on accounting principles or audit scope occurred during Marcum's tenure.
Material weaknesses in internal control over financial reporting were disclosed for 2024 and 2023.
Marcum provided a letter agreeing with the statements in this 8-K filed as Exhibit 16.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.